Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
C7zqjDBAtX2khkgj
Listen
